Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Frequently asked questions
What sector does Tecan Group Ltd (TCGGY) operate in?
Tecan Group Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Tecan Group Ltd (TCGGY) current stock price?
As of the latest data, Tecan Group Ltd stock price is $52.50, with a previous close of $52.50.
What is Tecan Group Ltd (TCGGY) current market capitalization?
Tecan Group Ltd market cap is approximately 3.23 billion.
What is Tecan Group Ltd (TCGGY) Earnings Per Share (EPS)?
The trailing EPS is -$2.31.
What is Tecan Group Ltd (TCGGY) EBITDA?
Tecan Group Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 46.60 million.
Does Tecan Group Ltd (TCGGY) pay dividends?
Yes. Tecan Group Ltd pays annual dividends with an annualized yield of 1.46% and an estimated annual payout of $0.77 per share.
When is the next ex-dividend date for Tecan Group Ltd (TCGGY)?
The next ex-dividend date is scheduled for April 20, 2027.
What is Tecan Group Ltd (TCGGY) beta (volatility) score?
Tecan Group Ltd has a beta of 1.007, meaning its volatility is roughly in line with the market.
